Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: A multicentre, open-label, 52-week phase III trial
Journal of Neurology, Neurosurgery & Psychiatry | Aug 15, 2017
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Clinical Pharmacology: Advances and Applications | Aug 15, 2017
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
Clinical Pharmacology: Advances and Applications | Aug 12, 2017
|